| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 2,848,544 | 2,700,939 | ||
| General and administrative | 3,147,291 | 1,949,035 | ||
| Operating loss | -5,995,835 | -4,649,974 | ||
| Issuance cost and change in fair value of derivative | 772,169 | - | ||
| Interest and other income (expense), net | -573,058 | -138,761 | ||
| Loss before income taxes | -7,341,062 | -4,788,735 | ||
| Income tax benefit (expense) | - | 0 | ||
| Net loss and comprehensive loss | -7,341,062 | -4,788,735 | ||
| Net loss per share of common stock, basic | -1.35 | -1.09 | ||
| Net loss per share of common stock, diluted | -1.35 | -1.09 | ||
| Weighted average number of shares used in computing net loss per share of common stock, basic | 5,431,206 | 4,389,465 | ||
| Weighted average number of shares used in computing net loss per share of common stock, diluted | 5,431,206 | 4,389,465 | ||
Cingulate Inc. (CING)
Cingulate Inc. (CING)